Results 141 to 150 of about 9,121 (212)

Adjuvant cytokine-induced killer cell immunotherapy in hepatocellular carcinoma: real-world data and 9-year extended follow-up of a randomized controlled trial. [PDF]

Cancer Immunol Immunother
Shin H, Park Y, Song BG, Choi WM, Han HJ, Lee Y, Song TJ, Yeon JE, Lim YS, Hur MH, Lee YB, Cho EJ, Yu SJ, Kim YJ, Lee JH, Yoon JH, Lee JH.   +16 more
europepmc   +1 more source

The Evolving Role of Immunotherapy in the Treatment with Curative Purpose of Early, Intermediate and Advanced Stage Hepatocellular Carcinoma. [PDF]

Curr Oncol
Karampa AD, Goussia A, Baltagiannis EG, Anastasopoulos NT, Christodoulou DK, Glantzounis GK.   +5 more
europepmc   +1 more source

Therapeutic Potential of CAR-CIK Cells in Acute Leukemia Relapsed Post Allogeneic Stem Cell Transplantation. [PDF]

Cancers (Basel)
Canichella M, de Fabritiis P, Abruzzese E.   +2 more
europepmc   +1 more source

Randomized pilot study of camrelizumab with or without autologous cytokine-induced killer cells in refractory clear cell renal cell carcinoma. [PDF]

Sci Rep
Li S, Qin J, Sun Q, Zhao H, Xiong Y, Wang Y, Han Y, Zhang J, Zhang W, Shen M, Yang F, Ren B, Zhou L, Li R, Hui Z, Tian X, Cao S, Du W, Yu W, Liu L, Zhang X, Ren X.   +21 more
europepmc   +1 more source

Synergistic antitumor efficacy of CIK cells combined with PD-1 inhibitors in nasopharyngeal carcinoma. [PDF]

Am J Transl Res
Chen J, Sailihan T, Chen Y, Xv S, Qian J, Shen X, Yang H, Zhang P.   +7 more
europepmc   +1 more source

Cik-cak kartice

Dijete, vrtić, obitelj : Časopis za odgoj i naobrazbu predškolske djece namijenjen stručnjacima i roditeljima, 2000
openaire   +1 more source

Rooting for order: How CIKs keep lateral growth in check [PDF]

Plant Physiology
Alicja B Kunkowska, Nicola Trozzi
openaire   +2 more sources

CIK-augmented anti-PD1/CTLA4 immunotherapy eradicates chemo-resistant ovarian cancer via tripartite mechanistic synergy. [PDF]

Front Oncol
Chen P, Pan J, Chen L, Feng X.
europepmc   +1 more source

From bench to bedside: advances in cell therapy for tuberculosis treatment. [PDF]

Stem Cell Res Ther
Chunxiao L, Junsheng F, Xuerong C, Xiaomin W, Shuihua L.   +4 more
europepmc   +1 more source

Overcoming heterogeneity and immunosuppression: novel strategies in adoptive therapy for biliary tract cancer. [PDF]

Front Immunol
Zhu Y, Xiong G, Guan M, Sun D, Guo Y, Peng J, Zhu H.   +6 more
europepmc   +1 more source